Ospicon is a Singapore-based company founded in 2014 by Derek Chong, Desmond Ng, Frank Fong and Victor Chan.
Ospicon invented BreathOptics, a technology that utilizes Optic Fiber sensors to couple BCG signal from human subjects to detect vital signs, using their optic fiber contact free sensor for detection of AOP (Preemies) and TTN (full-term) events of neonates.